Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab as a ...
Bristol-Myers Squibb has new data backing up the value of mavacamten for obstructive hypertrophic cardiomyopathy (HCM), as it waits for a delayed verdict on its marketing application for the drug, ...
Jefferies downgraded Syngene to 'underperform' and slashed price target to Rs 480 from Rs 660; JPMorgan downgraded Cipla to ...
Cardinal Health today reported second quarter fiscal year 2026 revenues of $65.6 billion, an increase of 19% from the second quarter of fiscal year 2025. Second quarter GAAP operating earnings ...
With $800 million in federal aid, developers of light-water small modular reactors are racing to build supply chains, ...
With nearly two decades of retail and project management experience, Brett Day can simplify traditional and Agile project management philosophies and methodologies and explain the features of project ...
Experts explore 3-year clinical data on bimekizumab presented at the 2025 EADV and SHSA congresses, highlighting its durable and ...
Anime-inspired games on Roblox are pretty much a dime a dozen, but Project Slayers is arguably one of the best. Not only does it boast deep RPG mechanics, a leveling system, and an open world, but it ...
The former CEO of Humana sat down with Newsweek for a Pulse Check.
Whether you're trying to chat with team members, organize a project, or work on a shared spreadsheet, the top online collaboration tools we've tested can help. I'm an expert in software and ...
Bitcoin on the cusp of $60,000 as investors flee risky bets Bitcoin made a 16-month low and tested key $60,000 support on Friday, as a global selloff in technology stocks deepened and washed out risky ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results